Scilex Says Private Investment Group to Buy $100M in Newly Issued Shares

Dow Jones

07/06

Scilex Holding said a private investment group will purchase $100 million of its newly issued shares under a binding term sheet.

The investment will help Scilex expand its healthcare and medical technology initiatives and also support product development, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, as well as other general corporate purposes, the company said Monday.

The purchase price by iHolding Group for the Scilex shares is expected to be $15.00 apiece, which would represent about 6.7 million shares.

The investment is still subject to customary closing conditions.

Scilex focuses on acquiring, developing and commercializing non-opioid pain-management products to treat acute and chronic pain, and neurodegenerative and cardiometabolic diseases.

iHolding is headquartered in the Republic of Kazakhstan.

Write to Freddy Sebastian at freddy.sebastian@wsj.com

(END) Dow Jones Newswires

July 06, 2026 06:26 ET (10:26 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

應版權方要求，你需要登入查看該內容

登入 / 註冊

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/news/2649650623"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2649650623\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2649650623?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-07-06 18:26","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2649650623","market":"us","top_or_hot":-1,"title":"Scilex Says Private Investment Group to Buy $100M in Newly Issued Shares","media":"Dow Jones","content":"<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Scilex Holding said a private investment group will purchase $100 million of its newly issued shares under a binding term sheet. \n</p>\n<p>\n  The investment will help Scilex expand its healthcare and medical technology initiatives and also support product development, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, as well as other general corporate purposes, the company said Monday. \n</p>\n<p>\n  The purchase price by iHolding Group for the Scilex shares is expected to be $15.00 apiece, which would represent about 6.7 million shares. \n</p>\n<p>\n  The investment is still subject to customary closing conditions. \n</p>\n<p>\n  Scilex focuses on acquiring, developing and commercializing non-opioid pain-management products to treat acute and chronic pain, and neurodegenerative and cardiometabolic diseases. \n</p>\n<p>\n  iHolding is headquartered in the Republic of Kazakhstan. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 06, 2026 06:26 ET (10:26 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Scilex Says Private Investment Group to Buy $100M in Newly Issued Shares</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nScilex Says Private Investment Group to Buy $100M in Newly Issued Shares\n</h2>\n<h4 class=\"meta\">\n<div class=\"head\" \">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Dow Jones </p>\n<p class=\"h-time smaller\">2026-07-06 18:26</p>\n</div>\n</div>\n</h4>\n</header>\n<article>\n<font class=\"NormalMinus1\" face=\"Arial\">\n<pre style=\"white-space: pre\">\n \n</pre>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Scilex Holding said a private investment group will purchase $100 million of its newly issued shares under a binding term sheet. \n</p>\n<p>\n  The investment will help Scilex expand its healthcare and medical technology initiatives and also support product development, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, as well as other general corporate purposes, the company said Monday. \n</p>\n<p>\n  The purchase price by iHolding Group for the Scilex shares is expected to be $15.00 apiece, which would represent about 6.7 million shares. \n</p>\n<p>\n  The investment is still subject to customary closing conditions. \n</p>\n<p>\n  Scilex focuses on acquiring, developing and commercializing non-opioid pain-management products to treat acute and chronic pain, and neurodegenerative and cardiometabolic diseases. \n</p>\n<p>\n  iHolding is headquartered in the Republic of Kazakhstan. \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n</p>\n<pre style=\"white-space: pre\">\n \n</pre>\n<p>\n  (END) Dow Jones Newswires\n</p>\n<p>\n  July 06, 2026 06:26 ET (10:26 GMT)\n</p>\n<p>\n  Copyright (c) 2026 Dow Jones &amp; Company, Inc.\n</p>\n</font>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SCLX","symbol_name":"Scilex Holding Company","start_time":0,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","article_id":"2649650623","we_media_id":"106","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2649650623","pubTimestamp":1783333560,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Dow Jones","introduction":"Dow Jones publishes the world’s most trusted business news and financial information in a variety of media.","home_visible":0,"id":"106","head_image":"https://static.tigerbbs.com/150f88aa4d182df19190059f4a365e99"},"summary":"Scilex Holding said a private investment group will purchase $100 million of its newly issued shares under a binding term sheet.The investment will help Scilex expand its healthcare and medical technology initiatives and also support product development, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, as well as other general corporate purposes, the company said Monday.The purchase price by iHolding Group for the Scilex shares is expected to be $15.00 apiece, which would represent about 6.7 million shares.The investment is still subject to customary closing conditions.Scilex focuses on acquiring, developing and commercializing non-opioid pain-management products to treat acute and chronic pain, and neurodegenerative and cardiometabolic diseases.iHolding is headquartered in the Republic of Kazakhstan.Write to Freddy Sebastian at freddy.sebastian@wsj.com Dow Jones NewswiresJuly 06, 2026 06:26 ET Copyright  2026 Dow Jones &","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SCLX":"Scilex Holding Company","BK4007":"制药"},"translate_title":"Scilex表示私人投资集团将购买1亿美元的新发行股票","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SCLX":0.9},"content_text":"Scilex Holding said a private investment group will purchase $100 million of its newly issued shares under a binding term sheet. \n\n\n  The investment will help Scilex expand its healthcare and medical technology initiatives and also support product development, acquisitions and strategic partnerships, working capital and operational growth, intellectual property expansion, as well as other general corporate purposes, the company said Monday. \n\n\n  The purchase price by iHolding Group for the Scilex shares is expected to be $15.00 apiece, which would represent about 6.7 million shares. \n\n\n  The investment is still subject to customary closing conditions. \n\n\n  Scilex focuses on acquiring, developing and commercializing non-opioid pain-management products to treat acute and chronic pain, and neurodegenerative and cardiometabolic diseases. \n\n\n  iHolding is headquartered in the Republic of Kazakhstan. \n\n\n \n\n\n  Write to Freddy Sebastian at freddy.sebastian@wsj.com \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  July 06, 2026 06:26 ET (10:26 GMT)\n\n\n  Copyright (c) 2026 Dow Jones & Company, Inc.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":true,"editions":null,"column":"","sentiment":"1","news_tag":"shareholding","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":true,"need_login_tip":false,"code":"91000000","status":"200"}}}